ConductScience.org, home

Paper782834

Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Pinder RM and 4 others. Drugs, 1976. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. Papers, record 782834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/782834

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
PubMed
Journal
Drugs
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
4.22
iCite
Revised in PubMed
2026-10-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinder RMR M
2Brogden RNR N
3Sawyer PRP R
4Speight TMT M
5Avery GSG S

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenserazideMajor topic
CarbidopaMajor topic
Carboxy-LyasesMajor topic
HydrazinesMajor topic
LevodopaMajor topic
Parkinson DiseaseMajor topic
Binding Sites
Drug Interactions
Humans
Kinetics
Liver Function Tests

Source PubMed

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,691,682Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.J Neurol Neurosurg Psychiatry1973https://conductscience.org/library/papers/4691682PubMed
24,217,929[Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].Rev Neurol (Paris)1974https://conductscience.org/library/papers/4217929PubMed
34,750,934[Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].Med Welt1973https://conductscience.org/library/papers/4750934PubMed
45,115,985[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].Wien Med Wochenschr1971https://conductscience.org/library/papers/5115985PubMed
54,114,458Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.Z Neurol1972https://conductscience.org/library/papers/4114458PubMed
64,695,662[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].Arch Psychiatr Nervenkr (1970)1973https://conductscience.org/library/papers/4695662PubMed
74,769,026[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].Psychopharmacologia1973https://conductscience.org/library/papers/4769026PubMed
84,155,220Abnormal involuntary movements induced by anticholinergic therapy.Acta Neurol Scand1974https://conductscience.org/library/papers/4155220PubMed
94,275,492[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].Wien Med Wochenschr1974https://conductscience.org/library/papers/4275492PubMed
105,577,486Cardiovascular effects of levodopa.Clin Pharmacol Ther1971https://conductscience.org/library/papers/5577486PubMed
111,107,835Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.N Engl J Med1976https://conductscience.org/library/papers/1107835PubMed
125,026,378Levodopa and pressor amine sensitivity in parkinsonism.Clin Pharmacol Ther1972https://conductscience.org/library/papers/5026378PubMed
134,698,567Potentiation of levodopa stimulation of human growth hormone by systemic decarboxylase inhibition.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4698567PubMed
145,067,774Melatonin and parkinsonism.JAMA1972https://conductscience.org/library/papers/5067774PubMed
154,197,759[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].Munch Med Wochenschr1973https://conductscience.org/library/papers/4197759PubMed
164,143,315Treatment of parkinsonism with bromocriptine.Lancet1974https://conductscience.org/library/papers/4143315PubMed
1752,131Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease.Neurology1975https://conductscience.org/library/papers/52131PubMed
184,628,192[Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].Nervenarzt1972https://conductscience.org/library/papers/4628192PubMed
194,365,556Morphological and biochemical studies on liver biopsies of parkinsonian patients treated with levodopa and decarboxylase inhibitor.Acta Neurol Scand1974https://conductscience.org/library/papers/4365556PubMed
205,293,414Adverse clinical side effects of levodopa therapy.Contemp Neurol Ser1971https://conductscience.org/library/papers/5293414PubMed

See all 107 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
24,128,899Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging.Nucl Med Commun2013https://conductscience.org/library/papers/24128899PubMed
21,486,284Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.Br J Pharmacol2011https://conductscience.org/library/papers/21486284PubMed
15,548,480Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.J Neurol Neurosurg Psychiatry2004https://conductscience.org/library/papers/15548480PubMed
8,828,615Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients.Eur J Pediatr1996https://conductscience.org/library/papers/8828615PubMed
8,792,058Pharmacokinetic optimisation in the treatment of Parkinson's disease.Clin Pharmacokinet1996https://conductscience.org/library/papers/8792058PubMed
7,946,003A risk-benefit assessment of drugs used in the management of Parkinson's disease.Drug Saf1994https://conductscience.org/library/papers/7946003PubMed
7,807,950Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria.J Inherit Metab Dis1994https://conductscience.org/library/papers/7807950PubMed
7,049,658Fixed combination drug therapy.Drugs1982https://conductscience.org/library/papers/7049658PubMed
6,617,727Intestinal absorption of levodopa in man.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6617727PubMed
3,927,334The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3927334PubMed
2,775,615The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2775615PubMed
2,404,503The influence of levodopa on gastric emptying in man.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2404503PubMed
2,119,841The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.Br J Pharmacol1990https://conductscience.org/library/papers/2119841PubMed
1,761,075Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1761075PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/782834

GET https://conductscience.org/api/papers/v1/782834/references?page=2